311 Views

Session: Still the One? Debating Vancomycin as First-Line MRSA Agent in New Era of AUC/MIC Dosing and Monitoring

819 - Con: It Is Time for Alternative MRSA Agents

Friday, October 21, 2022

8:30 AM – 9:00 AM US ET

Location: 147 AB

All relevant financial disclosures have been mitigated.

Speaker(s)

Disclosure(s):

Jamie L. Wagner, PharmD, BCPS, BCIDP: Shionogi & Co., Ltd.: Advisor/Consultant (Ongoing)